Crosspoint Capital Strategies’s MetLife MET Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2016
Q1
Sell
-84
Closed -$4K 538
2015
Q4
$4K Sell
84
-13,060
-99% -$574K ﹤0.01% 837
2015
Q3
$552K Sell
13,144
-28,794
-69% -$1.35M 0.64% 43
2015
Q2
$2.09M Buy
41,938
+20,400
+95% +$966K 0.59% 39
2015
Q1
$970K Buy
21,538
+752
+4% +$33.8K 0.47% 63
2014
Q4
$1M Buy
20,786
+20,674
+18,459% +$982K 0.35% 86
2014
Q3
$5K Hold
112
﹤0.01% 423
2014
Q2
$5K Buy
+112
New +$5.24K ﹤0.01% 445

Other funds holding MET

Crosspoint Capital Strategies's MET Position: Q1 2016 in Review

Crosspoint Capital Strategies sold out of MetLife (MET) in Q1 2016, closing a stake of 84 shares — an estimated $4K sold.

Crosspoint Capital Strategies first reported a position in MET in Q2 2014 and held it in 7 quarters. The position peaked at $2.09M in Q2 2015. 970 funds tracked by Wall St. Rank hold MET as of Q1 2016.

  • Crosspoint Capital Strategies reported no remaining MetLife position as of Q1 2016 after selling out during the quarter.
  • Crosspoint Capital Strategies sold 84 MetLife shares in Q1 2016, an estimated $4K.
  • Crosspoint Capital Strategies first reported a position in MetLife in Q2 2014 and held it in 7 quarters.
  • Crosspoint Capital Strategies's MetLife position peaked at $2.09M in Q2 2015.
  • 970 funds tracked by Wall St. Rank held MetLife as of Q1 2016.

Based on Crosspoint Capital Strategies's 13F filing for Q1 2016, filed 16 May 2016.